EP 1320585 A2 20030625 - OXIDOREDUCTASES
Title (en)
OXIDOREDUCTASES
Title (de)
OXIDOREDUKTASEN
Title (fr)
OXYDOREDUCTASES
Publication
Application
Priority
- US 0130656 W 20010928
- US 23710100 P 20000929
- US 23848200 P 20001006
- US 24402400 P 20001027
- US 25080500 P 20001201
Abstract (en)
[origin: WO0226951A2] The invention provides human oxidoreductases (OXIRED) and polynucleotides which identify and encode OXIRED. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of OXIRED.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/44 (2006.01); A61K 45/00 (2006.01); A61P 43/00 (2006.01); C07K 16/40 (2006.01); C07K 19/00 (2006.01); C12M 1/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 9/02 (2006.01); C12N 15/02 (2006.01); C12N 15/09 (2006.01); C12N 15/53 (2006.01); C12P 21/08 (2006.01); C12Q 1/02 (2006.01); C12Q 1/26 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 37/00 (2006.01)
CPC (source: EP)
A61P 43/00 (2017.12); C12N 9/0004 (2013.01)
Citation (search report)
See references of WO 0226951A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0226951 A2 20020404; WO 0226951 A3 20030327; AU 1132402 A 20020408; CA 2423701 A1 20020404; EP 1320585 A2 20030625; JP 2004524814 A 20040819
DOCDB simple family (application)
US 0130656 W 20010928; AU 1132402 A 20010928; CA 2423701 A 20010928; EP 01979351 A 20010928; JP 2002530715 A 20010928